Efficacy of dual enkephalinase inhibition in a preclinical migraine model is mediated by activation of peripheral delta opioid receptors.

Mei HR, Hu YY, Kapadia S, Ouimet T, Poras H, Dussor G

Open source

DOI
10.1111/head.14517
Published
2023 May
Container
Headache
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/head.14517,
  title = {Efficacy of dual enkephalinase inhibition in a preclinical migraine model is mediated by activation of peripheral delta opioid receptors.},
  author = {Mei HR and Hu YY and Kapadia S and Ouimet T and Poras H and Dussor G},
  year = {2023},
  journal = {Headache},
  doi = {10.1111/head.14517},
  url = {https://doi.org/10.1111/head.14517}
}

RIS

TY  - JOUR
TI  - Efficacy of dual enkephalinase inhibition in a preclinical migraine model is mediated by activation of peripheral delta opioid receptors.
AU  - Mei HR
AU  - Hu YY
AU  - Kapadia S
AU  - Ouimet T
AU  - Poras H
AU  - Dussor G
PY  - 2023
JO  - Headache
DO  - 10.1111/head.14517
UR  - https://doi.org/10.1111/head.14517
ER  - 

APA

HR, M., YY, H., S, K., T, O., H, P., & G, D. (2023). Efficacy of dual enkephalinase inhibition in a preclinical migraine model is mediated by activation of peripheral delta opioid receptors.. Headache. https://doi.org/10.1111/head.14517

Source records